secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2025-06-03T23:59:59+00:00
Accession:  0001213900-25-050822
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Pharma issues $1M unsecured note at 15% interest; CEO personally guarantees
--------------------------------------------------------------------------------

- $1M principal unsecured promissory note issued to Pagoda Resources on June 2, 2025.
- Interest rate 15% per year, compounded monthly; mature date December 2, 2025.
- Company may prepay at any time without penalty; note non-convertible.
- CEO Leonard Mazur provides unconditional personal guaranty of full repayment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390025050822/0001213900-25-050822-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390025050822/ea0244492-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-050822

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer